Active, Not Recruiting
AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
NCT06245915
- Conditions
- Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- City of Hope Duarte, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- University of Iowa and Holden Comprehensive Cancer Center Iowa City, Iowa, United States